Strata Critical Medical, Inc. (SRTA)
(Delayed Data from NSDQ)
$4.06 USD
-0.12 (-2.87%)
Updated Sep 5, 2025 04:00 PM ET
After-Market: $4.06 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SRTA 4.06 -0.12(-2.87%)
Will SRTA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SRTA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SRTA
The Zacks Analyst Blog Highlights Joby Aviation, Archer Aviation and Strata Critical Medical
JOBY's Premium Valuation: Should You Buy, Sell or Hold the Stock Now?
SRTA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for SRTA
50 Day Moving Average Resistance appears for SRTA after 2.87% move
SRTA forms 20 Day Moving Average Resistance on September 4
20 Day Moving Average Resistance appears for SRTA after 2.58% move
50 Day Moving Average Support appears for SRTA after 2.52% move
Strata Critical Medical to Present at the 2025 Jefferies Industrials Conference | SRTA Stock News